BridgeBio Pharma GAAP EPS of -$0.20 beats by $0.31, revenue of $211.12M beats by $127.34M (NASDAQ:BBIO)

0


  • BridgeBio Pharma press release (NASDAQ:BBIO): Q1 GAAP EPS of -$0.20 beats by $0.31.
  • Revenue for the three months ended March 31, 2024, were $211.1 million, as compared to $1.8 million for the same period in the prior year. The $209.3 million net increase for the three months ended



Source link

Leave A Reply

Your email address will not be published.